Latest California Healthline Stories
Podcast: KHN’s ‘What The Health?’ Campaign Promises Kept, Plus ‘Nerd Reports’
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Sarah Kliff of Vox and Alice Ollstein of Talking Points Memo discuss a proposed administration regulation that seeks to separate Planned Parenthood from federal family planning funds, the final congressional passage of legislation aimed at helping those with terminal illnesses obtain experimental medications, and new government reports on the uninsured and federal health spending. Also, Rovner interviews KHN’s Liz Szabo about the May “Bill of the Month.”
Drugmakers Blamed For Blocking Generics Have Jacked Up Prices And Cost U.S. Billions
The Trump administration is shaming brand-name drugmakers who refuse to sell samples so generics can be made from their products.
Indocumentada y con cáncer: entre la muerte y la deportación
¿Qué sucede cuando un inmigrante indocumentado tiene un diagnóstico potencialmente mortal? Depende mucho de en dónde viva.
Por qué Trump quiere quitarle fondos a Planned Parenthood
La reactivación de una norma que data de la presidencia de Ronald Reagan podría ayudar al presidente a cumplir su promesa de campaña de “cancelar” Planned Parenthood.
Trump Proposes Cutting Planned Parenthood Funds. What Does That Mean?
The Trump administration is pulling out an old regulation that it believes will be able to meet a key conservative goal: withholding some federal funding for Planned Parenthood in the government’s family planning program.
Choosing Between Death And Deportation
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
Podcast: KHN’s ‘What The Health?’ Much Ado About Drug Prices
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
Trump Vows (Again) To Lower Drug Prices But Skeptics Doubt Much Will Change
President Donald Trump’s much-awaited speech about slashing drug costs was long on rhetoric but short on specifics that will reduce prices.
Consumers Brace For Premium Hikes While Lawmakers Grasp At Remedies
Health insurers’ initial premium requests indicate stiff price hikes for consumers, just as bipartisan talks in Congress fall flat.
Por plan de Trump, inmigrantes podrían tener miedo de recibir beneficios de salud
Bajo la norma propuesta, el que un immigrante haya usado beneficios públicos como Medicaid o SNAP, puede poner en peligro el proceso para obtener la residencia permanente.